2016
DOI: 10.1021/jacs.6b01563
|View full text |Cite
|
Sign up to set email alerts
|

Domain Movements upon Activation of Phenylalanine Hydroxylase Characterized by Crystallography and Chromatography-Coupled Small-Angle X-ray Scattering

Abstract: Mammalian phenylalanine hydroxylase (PheH) is an allosteric enzyme that catalyzes the first step in the catabolism of the amino acid phenylalanine. Following allosteric activation by high phenylalanine levels, the enzyme catalyzes the pterin-dependent conversion of phenylalanine to tyrosine. Inability to control elevated phenylalanine levels in the blood leads to increased risk of mental disabilities commonly associated with the inherited metabolic disorder, phenylketonuria. Although extensively studied, struc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

12
194
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 115 publications
(209 citation statements)
references
References 59 publications
(244 reference statements)
12
194
1
Order By: Relevance
“…The present results predict that the quaternary structure of TPH1, and likely TPH2, resembles those of TyrH[25] and phenylalanine-activated PheH[10, 18]. Figure 4 shows a model for the structure of the dimer of the regulatory domain of tTPH1 based on these structures.…”
Section: Resultsmentioning
confidence: 63%
See 2 more Smart Citations
“…The present results predict that the quaternary structure of TPH1, and likely TPH2, resembles those of TyrH[25] and phenylalanine-activated PheH[10, 18]. Figure 4 shows a model for the structure of the dimer of the regulatory domain of tTPH1 based on these structures.…”
Section: Resultsmentioning
confidence: 63%
“…Key to this conformational change is formation of an ACT domain dimer by regulatory domains from two subunits[17, 18]. This model is supported by recent studies of the isolated regulatory domain[14, 19, 20] and of the intact protein[13, 18]. TyrH is activated by phosphorylation of Ser40 in its N-terminal regulatory domain and inhibited by catecholamines[10, 21].…”
mentioning
confidence: 94%
See 1 more Smart Citation
“…However, the equilibrium between RS-PAH and A-PAH depends upon Phe binding to another site on the protein, called the allosteric site, which is formed by a structural change repositioning various parts of the PAH protein in the transition from RS-PAH to A-PAH. The precise structural location of this allosteric site, which Fig 1 shows as present only in the A-PAH structure, was first hypothesized in 2013 (16); it is now strongly supported by newly published structural studies (1720). In contrast, some earlier studies had generally suggested that allosteric Phe binding involved an intermolecular interaction involving the regulatory domain; these studies were interpreted solely on the basis of an RS-PAH structure model and did not foresee the conformational change required for formation of A-PAH (e.g.…”
Section: Regulation Of Phe In Humansmentioning
confidence: 65%
“…For conformational differences, the resulting SAXS data may still be used for ensemble modeling, but mass differences will require more careful purification or optimization of preparation protocols. A recently-described use of evolving factor analysis in preparation of SAXS samples by SEC may be useful for differentiating complex elution profiles [48]. …”
Section: Theory and Applicationsmentioning
confidence: 99%